Cell-mediated graft rejection observed in two lines of human histocompatibility leukocyte antigen class I transgenic mice

Transplantation

Volumn 68, Issue 6, 1999, Pages 904-908

  Ando, Yuichi ^a   Beck, Yoshifumi ^a   Tomikawa, Shinji ^a   Eriguchi, Masazumi ^a   Muto, Tetsuichiro ^a   Takiguchi, Masafumi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELL LINE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HEART GRAFT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; TRANSGENIC MOUSE;

ANIMALS; EPITOPES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HUMANS; IMMUNITY, CELLULAR; MALE; MICE; MICE, INBRED C3H; MICE, TRANSGENIC; PHENOTYPE; SKIN TRANSPLANTATION;

EID: 0033610285     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199909270-00026     Document Type: Article

References (10)

1. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 1979; 27: 51.
2. Rammensee HG. Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol 1995; 7: 85.
3. Hämerling GJ, Chamberlain JW, Dill O, et al. Self-tolerance to HLA focuses the response of immunized HLA-transgenic mice on production of antibody to precise polymorphic HLA alloantigens. Proc Natl Acad Sci USA 1990; 87: 235.
4. Karaki S, Kariyone A, Kato N, Kano K, Iwakura Y, Takiguchi M. HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies. Immunogenetics 1993; 37: 139.
5. Schönbach C, Nokihara K, Bangham CR, et al. Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice. Virology 1996; 226: 102.
6. Billingham RE, Meadwar PB. Technique of free skin grafting in mammals. J Exp Biol 1951; 28: 385.
7. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
8. Ooba T, Hayashi H, Karaki S, Tanabe M, Kano K, Takiguchi M. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 1989; 30: 76.
9. Barra C, Gournier H, Garcia Z, et al. Abrogation of H-2-restricted CTL responses and efficient recognition of HLA-A3 molecules in DBA/2 HLA/A24 responder mice. J Immunol 1993; 150: 3681.
10. Kalinke U, Arnold B, Hämmerling GJ. Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27. Nature 1990; 348: 642.